The history of the erectile dysfunction drug presents a complex picture for shareholders. While the initial launch generated significant returns, the lapse of its patent opened the avenue to generic alternatives, https://bookmarkspiral.com/story21640505/sildenafil-and-big-pharma-a-precarious-bet